Lim Chi-Yeon, Kim Bu-Yeo, Lim Se-Hyun, Cho Su-In
Department of Medicine, College of Medicine, Dongguk University, Ilsan, Republic of Korea.
Department of Medical Research, Korea Institute of Oriental Medicine, Daejon 305-701, Republic of Korea.
Pharmacogn Mag. 2015 Apr-Jun;11(42):395-403. doi: 10.4103/0973-1296.153095.
Co-administration of Angelicae gigantis radix (AGR) and Lithospermi radix (LR) has been commonly applied to patients to treat cardiac and hepatic disorders. Individual bioactivities of these herbal medicines have been widely investigated, but the hepatoprotective effects of co-treatment of AGR and LR have yet to be clarified.
The present study investigated the protective effects of extracts of AGR and LR on carbon tetrachloride (CCl4) induced hepatic injury.
In this study, we measured the hepatoprotective activity of individual and co-treatment of the two herbal medicines on hepatic injury induced by CCl4 by measuring different biochemical parameters such as serum aspartate aminotransaminase (AST) and serum alanine aminotransaminase (ALT). Microarray technology also used to compare ontological difference with individual and co-treatment of these two.
Combined treatment with AGR and LR (AGR + LR) decreased AST and ALT level in serum which demonstrate hepatoprotective effect of the therapy. When the effect of AGR and LR according to treatment conditions was measured, co-treatment showed the most prominent effect on hepatic injury by CCl4 rather than individual treatment condition. We further defined gene set that could be the molecular target of herbal effect on hepatic injury by CCl4 using bioinformatical analysis of interaction network. Highly recovered genes by treating AGR + LR play significant roles in response to hepatic injury induced by CCl4.
Combined treatment with AGR and LR showed synergistic protective effects on the CCl4-induced rat hepatic tissue injury.
当归(AGR)和紫草(LR)联合应用常用于治疗心脏和肝脏疾病的患者。这些草药的个体生物活性已得到广泛研究,但AGR和LR联合治疗的肝保护作用尚未明确。
本研究探讨AGR和LR提取物对四氯化碳(CCl4)诱导的肝损伤的保护作用。
在本研究中,我们通过测量不同的生化参数,如血清天冬氨酸氨基转移酶(AST)和血清丙氨酸氨基转移酶(ALT),来测定两种草药单独及联合治疗对CCl4诱导的肝损伤的肝保护活性。微阵列技术也用于比较这两种草药单独及联合治疗的本体差异。
AGR和LR联合治疗(AGR + LR)可降低血清中AST和ALT水平,表明该疗法具有肝保护作用。当根据治疗条件测量AGR和LR的效果时,联合治疗对CCl4诱导的肝损伤显示出最显著的效果,而不是单独治疗条件。我们通过对相互作用网络的生物信息学分析,进一步确定了可能是草药对CCl4诱导的肝损伤作用的分子靶点的基因集。通过AGR + LR治疗高度恢复的基因在对CCl4诱导的肝损伤的反应中起重要作用。
AGR和LR联合治疗对CCl4诱导的大鼠肝组织损伤具有协同保护作用。